Recommendations for neonatal surfactant therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.European journal of pediatrics · 2020
   Trial
2. Meconium aspiration syndrome: from pathophysiology to treatment.Annals of medicine and surgery (2012) · 2024
   Review
3. Meconium Aspiration Syndrome: A Narrative Review.Children (Basel, Switzerland) · 2021
   Review
4. "Optimal surfactant delivery protocol using the bovine lipid extract surfactant: a quality improvement study".Journal of perinatology : official journal of the California Perinatal Association · 2021
   Article
5. Characteristics and outcomes of preterm neonates according to number of doses of surfactant received.Journal of perinatology : official journal of the California Perinatal Association · 2021
   Article
6. Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?Medical hypotheses · 2020
   Article
7. Deposition of Aerosolized Lucinactant in Nonhuman Primates.Journal of aerosol medicine and pulmonary drug delivery · 2020
   Article
8. Criteria for Using INSURE in Management of Premature Babies with Respiratory Distress Syndrome.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2019
   Article
9. Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial.Paediatrics & child health · 2017
   Article
10. The use of equine surfactant and positive pressure ventilation to treat a premature alpaca cria with severe hypoventilation and hypercapnia.The Canadian veterinary journal = La revue veterinaire canadienne · 2015
    Article
11. The use of surfactant in the neonatal period- the known aspects, those still under research and those which need to be investigated further.Turk pediatri arsivi · 2014
    Review
12. Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?BMC pediatrics · 2013
    Review
13. Advances in the management of meconium aspiration syndrome.International journal of pediatrics · 2012
    Article
14. Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality.BMC health services research · 2011
    Article
15. A role for community health care providers in neonatal follow-up.Paediatrics & child health · 2006
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.